In vitro activity of anti-rheumatic drugs on release of pro-inflammatory cytokines from oral cells in interaction with microorganisms

Periodontitis patients suffering concomitantly from rheumatoid arthritis (RA) often present with less inflamed periodontal tissues due to the ongoing anti-rheumatic therapy. This in vitro study was aimed to analyze whether anti-inflammatory drugs used in the therapy of RA can modulate the release of...

Full description

Bibliographic Details
Main Authors: Alexandra Stähli, Carina Scherler, Graziano Zappalà, Anton Sculean, Sigrun Eick
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oral Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/froh.2022.960732/full
_version_ 1797858500836065280
author Alexandra Stähli
Carina Scherler
Graziano Zappalà
Anton Sculean
Sigrun Eick
author_facet Alexandra Stähli
Carina Scherler
Graziano Zappalà
Anton Sculean
Sigrun Eick
author_sort Alexandra Stähli
collection DOAJ
description Periodontitis patients suffering concomitantly from rheumatoid arthritis (RA) often present with less inflamed periodontal tissues due to the ongoing anti-rheumatic therapy. This in vitro study was aimed to analyze whether anti-inflammatory drugs used in the therapy of RA can modulate the release of IL-8 and IL-1β by professional and non-professional immune cells stimulated with microorganisms. Periodontal ligament (PDL) fibroblasts, monocytic MONO-MAC-6-cells, and gingival keratinocytes were exposed to ibuprofen, prednisolone, and methotrexate with and without lysates of Fusobacterium nucleatum or Candida albicans. Supernatants were obtained and the levels of interleukin(IL)-8 and IL-1β (only MONO-MAC-6) were quantified. The addition of F. nucleatum lysate resulted in the strongest release of proinflammatory cytokines by PDL fibroblast and MONO-MAC-6 cells, while the modification by the tested anti-rheumatic drugs was only minor. After stimulation of the MONO-MAC-cells with F. nucleatum, prednisolone increased the release of IL-8, whereas methotrexate decreased the level. Anti-inflammatory drugs increased the adherence of C. albicans to epithelial cells. In patients with RA, the reduction of the microbial load in subgingival biofilm (biofilm removal) is of major importance; however, the intake of inflammatory drugs may interfere with the inflammatory response.
first_indexed 2024-04-09T21:14:23Z
format Article
id doaj.art-b86409360ca5433e8cbfb012342ae2ce
institution Directory Open Access Journal
issn 2673-4842
language English
last_indexed 2024-04-09T21:14:23Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oral Health
spelling doaj.art-b86409360ca5433e8cbfb012342ae2ce2023-03-28T12:25:30ZengFrontiers Media S.A.Frontiers in Oral Health2673-48422022-09-01310.3389/froh.2022.960732960732In vitro activity of anti-rheumatic drugs on release of pro-inflammatory cytokines from oral cells in interaction with microorganismsAlexandra StähliCarina ScherlerGraziano ZappalàAnton SculeanSigrun EickPeriodontitis patients suffering concomitantly from rheumatoid arthritis (RA) often present with less inflamed periodontal tissues due to the ongoing anti-rheumatic therapy. This in vitro study was aimed to analyze whether anti-inflammatory drugs used in the therapy of RA can modulate the release of IL-8 and IL-1β by professional and non-professional immune cells stimulated with microorganisms. Periodontal ligament (PDL) fibroblasts, monocytic MONO-MAC-6-cells, and gingival keratinocytes were exposed to ibuprofen, prednisolone, and methotrexate with and without lysates of Fusobacterium nucleatum or Candida albicans. Supernatants were obtained and the levels of interleukin(IL)-8 and IL-1β (only MONO-MAC-6) were quantified. The addition of F. nucleatum lysate resulted in the strongest release of proinflammatory cytokines by PDL fibroblast and MONO-MAC-6 cells, while the modification by the tested anti-rheumatic drugs was only minor. After stimulation of the MONO-MAC-cells with F. nucleatum, prednisolone increased the release of IL-8, whereas methotrexate decreased the level. Anti-inflammatory drugs increased the adherence of C. albicans to epithelial cells. In patients with RA, the reduction of the microbial load in subgingival biofilm (biofilm removal) is of major importance; however, the intake of inflammatory drugs may interfere with the inflammatory response.https://www.frontiersin.org/articles/10.3389/froh.2022.960732/fullperiodontitisrheumatoid arthritisanti-inflammatory drugsproinflammatory cytokinesoral cells
spellingShingle Alexandra Stähli
Carina Scherler
Graziano Zappalà
Anton Sculean
Sigrun Eick
In vitro activity of anti-rheumatic drugs on release of pro-inflammatory cytokines from oral cells in interaction with microorganisms
Frontiers in Oral Health
periodontitis
rheumatoid arthritis
anti-inflammatory drugs
proinflammatory cytokines
oral cells
title In vitro activity of anti-rheumatic drugs on release of pro-inflammatory cytokines from oral cells in interaction with microorganisms
title_full In vitro activity of anti-rheumatic drugs on release of pro-inflammatory cytokines from oral cells in interaction with microorganisms
title_fullStr In vitro activity of anti-rheumatic drugs on release of pro-inflammatory cytokines from oral cells in interaction with microorganisms
title_full_unstemmed In vitro activity of anti-rheumatic drugs on release of pro-inflammatory cytokines from oral cells in interaction with microorganisms
title_short In vitro activity of anti-rheumatic drugs on release of pro-inflammatory cytokines from oral cells in interaction with microorganisms
title_sort in vitro activity of anti rheumatic drugs on release of pro inflammatory cytokines from oral cells in interaction with microorganisms
topic periodontitis
rheumatoid arthritis
anti-inflammatory drugs
proinflammatory cytokines
oral cells
url https://www.frontiersin.org/articles/10.3389/froh.2022.960732/full
work_keys_str_mv AT alexandrastahli invitroactivityofantirheumaticdrugsonreleaseofproinflammatorycytokinesfromoralcellsininteractionwithmicroorganisms
AT carinascherler invitroactivityofantirheumaticdrugsonreleaseofproinflammatorycytokinesfromoralcellsininteractionwithmicroorganisms
AT grazianozappala invitroactivityofantirheumaticdrugsonreleaseofproinflammatorycytokinesfromoralcellsininteractionwithmicroorganisms
AT antonsculean invitroactivityofantirheumaticdrugsonreleaseofproinflammatorycytokinesfromoralcellsininteractionwithmicroorganisms
AT sigruneick invitroactivityofantirheumaticdrugsonreleaseofproinflammatorycytokinesfromoralcellsininteractionwithmicroorganisms